The effect of type 2 diabetes on the prognosis of community-acquired pneumonia - Report - MDSpire

The effect of type 2 diabetes on the prognosis of community-acquired pneumonia

  • By

  • Fan-Shuo Kong

  • Long-Ye Zhang

  • Rui Wang

  • Chun-Ming Ma

  • July 14, 2026

Share

Impact of Type 2 Diabetes Mellitus on Outcomes in Patients with Community-Acquired Pneumonia

Overview

This study investigates the effects of type 2 diabetes mellitus (T2DM) on the severity and prognosis of community-acquired pneumonia (CAP) in a cohort of 2471 patients.

Background

Community-acquired pneumonia (CAP) is a significant global health issue with high incidence and mortality rates. Patients with underlying conditions, such as type 2 diabetes mellitus (T2DM), may experience worse outcomes.

Data Highlights

ParameterT2DM GroupNon-Diabetic GroupP-value
Septic Shock6.4%3.5%0.002
Respiratory Failure22.7%16.5%0.001
Mortality8.4%4.3%<0.001

Key Findings

  • 22.6% of CAP patients had T2DM.
  • Higher rates of septic shock (6.4% vs 3.5%) were observed in T2DM patients.
  • Respiratory failure occurred more frequently in T2DM patients (22.7% vs 16.5%).
  • The mortality rate was significantly higher in T2DM patients (8.4% vs 4.3%).
  • T2DM was identified as an independent risk factor for death in CAP inpatients (OR = 1.713).
  • In low and intermediate CURB-65 risk groups, T2DM was associated with increased in-hospital mortality.

Clinical Implications

Clinicians should be aware of the increased severity and mortality risk associated with T2DM in CAP patients.

Conclusion

The presence of T2DM in CAP patients correlates with worse clinical outcomes.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Impact of diabetes mellitus on mortality in patients with acute exacerbation of chronic obstructive Pulmonary disease: a meta-analysis and systematic review
  2. Frontiers in Endocrinology, 2026 -- The impact of comorbid type 2 diabetes on survival outcomes in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis focusing on lung cancer
  3. Infection, 2023 -- The Impact of Diabetes Mellitus on 90-Day Mortality Among Elderly Critically Ill Patients with COVID-19: Findings from a Multicenter Prospective Observational Study
  4. Journal of General Internal Medicine, 2026 -- Pneumonia Etiology and Risk Factors in a Tertiary Hospital During the COVID-19 Era: A Retrospective Analysis (2020–2024)
  5. Current guideline landscape for CAP
  6. NICE guideline NG250 on CAP
  7. Diabetes and CAP outcomes review
  8. Efficacy of corticosteroids in CAP
  9. SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence - PMC
  10. Sodium–glucose cotransporter-2 inhibitor therapy and risk of mortality and morbidity following hospitalization for pneumonia in type 2 diabetes mellitus: An international propensity score-matched cohort study - Anne Chang, Tien-Chun Yang, Anna Chang, Chien-Tai Hong, Ying-Hsuan Tai, 2026

Original Source(s)

Related Content